CD40LG and melanoma: Anti-GD1b, -GT1b, and -GQ1b (IgM type) influence the progression of melanoma [8, 52], soft tissue sarcomas [32, 33], Ehrlich subcutaneous solid tumors [11, 12], Ehrlich carcinomas accompanied by ascites [11, 12], and gastric cancer [34].